| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $15.03M | $15.89M | $29.39M | $25.80M | $19.29M |
| R&D | $9.20M | $10.62M | $19.01M | $18.69M | $12.88M |
| SG&A | $5.80M | $4.91M | $6.14M | $7.10M | $6.41M |
| Operating Income | -$15.03M | -$15.89M | -$29.39M | -$25.80M | -$19.29M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $382.65M | – | – | – | – |
| Net Income | $1.24B | -$15.01M | -$29.07M | -$31.06M | -$14.47M |
| EPS (basic) | 27.0400 | -0.7300 | -1.5600 | -1.6900 | – |
| EPS (diluted) | 25.4800 | -0.7300 | -1.5600 | -1.6900 | – |
| Shares (diluted) | $48.50M | $20.51M | $18.57M | – | – |